ALEXANDRIA, Va., June 25 -- United States Patent no. 12,336,992, issued on June 24, was assigned to THE BOARD OF TRUSTEES OF THE UNIVERSITY OF ILLINOIS (Urbana, Ill.).
"PAC-1 combination therapy" was invented by Paul J. Hergenrother (Champaign, Ill.) and Jessie Peh (Champaign, Ill.).
According to the abstract* released by the U.S. Patent & Trademark Office: "Compositions and methods for the induction of cancer cell death. The compositions and methods include use of compositions in therapy for the treatment of cancer and for the selective induction of apoptosis in cancer cells. The drug combinations described herein can be synergistic and can have lower neurotoxicity effects than the same amounts of other compounds and combinations of comp...